BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7188109)

  • 1. Significance of antithrombotic effect in drug therapy of the chronic arterial occlusive disease.
    Angelkort B
    Ric Clin Lab; 1981; 11 Suppl 1():215-21. PubMed ID: 7188109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease.
    Angelkort B; Kiesewetter H
    Scand J Clin Lab Invest Suppl; 1981; 156():185-8. PubMed ID: 6948383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood fluidity and coagulation phenomena in chronic arterial occlusive disease.
    Angelkort B; Boateng K; Maurin N
    J Int Med Res; 1980; 8(3):242-6. PubMed ID: 7389992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
    Angelkort B
    Med Welt; 1979 Aug; 30(34):1239-43. PubMed ID: 491921
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].
    Sternitzky R; Seige K
    Z Gesamte Inn Med; 1983 Jan; 38(1):1-7. PubMed ID: 6342278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Angelkort B
    Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorrheologic aspects in relation to the physiopathology and clinical aspects of peripheral occlusive arteriopathy].
    Perego MA; Sergio G; Artale F
    Ric Clin Lab; 1981; 11 Suppl 1():281-91. PubMed ID: 7188115
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
    Ehrly AM
    J Med; 1979; 10(5):331-8. PubMed ID: 294470
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of vincamine on blood viscosity].
    Ehrly AM; Landgraf H
    Fortschr Med; 1982 May; 100(20):969-71. PubMed ID: 7095712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
    Störmer B; Kleinschmidt F; Loose D; Kremer K
    Dtsch Med Wochenschr; 1978 Apr; 103(16):694-8. PubMed ID: 639718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific methods to determine hemorheological parameters.
    Kiesewetter H; Dauer U; Mussler K; Teitel P; Seiffge D; Schmid-Schönbein H
    Ric Clin Lab; 1981; 11 Suppl 1():125-33. PubMed ID: 7188105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease.
    Angelkort B; Maurin N; Boateng K
    Curr Med Res Opin; 1979; 6(4):255-8. PubMed ID: 527350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of blood-flow and erythrocyte properties in arterial occlusive diseases].
    Ehrly AM
    Med Welt; 1975 Oct; 26(43):1971-2. PubMed ID: 1196088
    [No Abstract]   [Full Text] [Related]  

  • 14. [Improvement of flow properties of blood: a new principle for drug therapy of chronic peripheral arterial vascular disorders].
    Ehrly AM
    Vasa Suppl; 1973; 1():1-18. PubMed ID: 4517911
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of pentoxifylline on the flow properties of human blood.
    Ehrly AM
    Curr Med Res Opin; 1978; 5(8):608-13. PubMed ID: 710175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of benfurodil hemiscucinate (Eucilat) on various hemorheologic parameters in patients with chronic peripheral obstructive arteriopathies].
    Mozzi E; Annoni F; Chiurazzi D; Rossi R; Pacini F; Martini A
    Minerva Cardioangiol; 1984 Mar; 32(3):141-9. PubMed ID: 6374499
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood coagulation and fibrinolytic system in patients with chronic occlusive peripheral artery disease treated with streptokinase].
    Zola-Sleczek E
    Kardiol Pol; 1973; 16(4):317-22. PubMed ID: 4756966
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and hemorrheologic effects of pentoxifylline in patients with obliterative arteriopathy of the legs].
    Vaya A; Martínez M; Carbonell P; Aznar J
    Angiologia; 1987; 39(6):262-8. PubMed ID: 3425972
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
    Runge E; Thiele P
    Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.